Literature DB >> 11888363

Health-related quality of life in a UK-based population of men with erectile dysfunction.

Julian F Guest1, Roben Das Gupta.   

Abstract

OBJECTIVE: To measure health-related quality of life (HR-QOL) among a sample of men with erectile dysfunction (ED) in the UK. STUDY POPULATION AND METHODS: A structured questionnaire was mailed to a sample of 5000 men in the UK with ED. The questionnaire included the International Index of Erectile Function (IIEF-5) scale to determine ED severity and the EuroQoL (EQ-5D) questionnaire, a generic HR-QOL instrument. Descriptive information relating to personal relationships and sociodemographics as well as details of comorbidities were also requested.
RESULTS: 23% of the sample (n = 1141) returned a completed questionnaire. Of the respondents, 82.2% (n = 939) met the criteria for ED based on the IIEF-5 scale. The mean age of the respondents was 60.4 +/- 24.9 years. There was a gradual convergence of respondents' HR-QOL scores to that of the normal male population as their age increased. The HR-QOL of respondents was significantly poorer than that of the normal population for those under 65 years of age, whereas it was significantly better for those between the ages of 65 and 74 years. Comorbid illness had a significant impact on the HR-QOL of respondents over 44 years of age. Furthermore, the HR-QOL of respondents with multiple risk factors for ED was significantly lower than that of respondents without any risk factors (p < 0.001). The respondents' HR-QOL was significantly poorer compared with the normal male population when stratified by marital status. It was also significantly poorer when stratified by whether the respondents were manual or non-manual workers.
CONCLUSION: HR-QOL among men with ED is poorer in those with comorbid illnesses and improves with age.

Entities:  

Mesh:

Year:  2002        PMID: 11888363     DOI: 10.2165/00019053-200220020-00004

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  21 in total

1.  Sexuality and aging in male veterans: a cross-sectional study of interest, ability, and activity.

Authors:  T Mulligan; C R Moss
Journal:  Arch Sex Behav       Date:  1991-02

Review 2.  The epidemiology and pathophysiology of erectile dysfunction.

Authors:  A Melman; J C Gingell
Journal:  J Urol       Date:  1999-01       Impact factor: 7.450

Review 3.  Pharmacotherapy in erectile dysfunction agents for self-injection programs and alternative application models.

Authors:  H Hedlund; P Hedlund
Journal:  Scand J Urol Nephrol Suppl       Date:  1996

4.  The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus.

Authors:  D Kohen; A P Burgess; J Catalán; A Lant
Journal:  Qual Life Res       Date:  1998-04       Impact factor: 4.147

5.  Quality of life effects of alprostadil therapy for erectile dysfunction.

Authors:  R J Willke; H A Glick; T J McCarron; M H Erder; S E Althof; O I Linet
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

6.  An empirical comparison of four generic health status measures. The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument.

Authors:  M L Essink-Bot; P F Krabbe; G J Bonsel; N K Aaronson
Journal:  Med Care       Date:  1997-05       Impact factor: 2.983

7.  Test-retest reliability of health state valuations collected with the EuroQol questionnaire.

Authors:  H M van Agt; M L Essink-Bot; P F Krabbe; G J Bonsel
Journal:  Soc Sci Med       Date:  1994-12       Impact factor: 4.634

8.  The Social Readjustment Rating Scale.

Authors:  T H Holmes; R H Rahe
Journal:  J Psychosom Res       Date:  1967-08       Impact factor: 3.006

9.  Quality of life in patients with ischaemic heart disease: a prospective controlled study.

Authors:  L Westin; R Carlsson; B Israelsson; R Willenheimer; C Cline; T F McNeil
Journal:  J Intern Med       Date:  1997-09       Impact factor: 8.989

10.  Quality of life in coronary artery disease.

Authors:  H Lukkarinen
Journal:  Nurs Res       Date:  1998 Nov-Dec       Impact factor: 2.381

View more
  17 in total

1.  Cavernous nerve stimulation and interposition grafting: a critical assessment and future perspectives.

Authors:  John P Mulhall
Journal:  Rev Urol       Date:  2005

Review 2.  New treatment options for erectile dysfunction in patients with diabetes mellitus.

Authors:  Ansu Basu; Robert E J Ryder
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Vardenafil.

Authors:  Douglas Ormrod; Stephanie E Easthope; David P Figgitt
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

4.  Association between body size and composition and erectile dysfunction in older men: Osteoporotic Fractures in Men Study.

Authors:  Pranav S Garimella; Misti L Paudel; Kristine E Ensrud; Lynn M Marshall; Brent C Taylor; Howard A Fink
Journal:  J Am Geriatr Soc       Date:  2013-01       Impact factor: 5.562

5.  Structural insights into aberrant cortical morphometry and network organization in psychogenic erectile dysfunction.

Authors:  Lu Zhao; Min Guan; Xiangsheng Zhang; Sherif Karama; Budhachandra Khundrakpam; Meiyun Wang; Minghao Dong; Wei Qin; Jie Tian; Alan C Evans; Dapeng Shi
Journal:  Hum Brain Mapp       Date:  2015-08-12       Impact factor: 5.038

Review 6.  Men's beliefs about treatment for erectile dysfunction-what influences treatment use? A systematic review.

Authors:  Paul Williams; Hayley McBain; Aliya Amirova; Stanton Newman; Kathleen Mulligan
Journal:  Int J Impot Res       Date:  2020-03-31       Impact factor: 2.896

7.  The validity of a single-question self-report of erectile dysfunction. Results from the Massachusetts Male Aging Study.

Authors:  Amy B O'Donnell; Andre B Araujo; Irwin Goldstein; John B McKinlay
Journal:  J Gen Intern Med       Date:  2005-06       Impact factor: 5.128

Review 8.  The Quality of Life and Economic Burden of Erectile Dysfunction.

Authors:  Dean S Elterman; Samir K Bhattacharyya; Michael Mafilios; Emily Woodward; Krista Nitschelm; Arthur L Burnett
Journal:  Res Rep Urol       Date:  2021-02-18

Review 9.  Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.

Authors:  Antonio Martín Morales; Vincenzo Mirone; John Dean; Pierre Costa
Journal:  Clin Interv Aging       Date:  2009-12-29       Impact factor: 4.458

10.  Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily.

Authors:  Fabrizio Iacono; Domenico Prezioso; Ester Illiano; Giuseppe Romeo; Antonio Ruffo; Bruno Amato
Journal:  BMC Surg       Date:  2012-11-15       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.